In vitro cellular responses to cytokines and erythropoietin

Area of Science:

• Pharmacology and Toxicology
• Cell Biology and Biochemistry

Background:

• Cytokines and polypeptide hormones signal through cell surface receptors, influencing gene expression and cellular responses like growth or inhibition.
• Accurate potency determination of bioactive substances is crucial for therapeutic applications.

Purpose of the Study:

• To establish and validate bioassay systems for determining the potency of human bioactive substances, including interferons (IFNs), IL-2, G-CSF, GM-CSF, and erythropoietin (Epo).
• To develop high-throughput methods for potency assessment, particularly for interferons.

Main Methods:

• Utilized cellular growth as an endpoint, measuring the conversion of MTT tetrazolium salt by mitochondrial reductase.
• Employed murine or human cell lines and a reporter gene-modified human glioblastoma line for high-throughput screening.
• Designed bioassays based on the parallel line assay model and validated extensively for precision and reproducibility.

Main Results:

• Bioassays demonstrated potency determination in the picomolar (pM) range, comparable in sensitivity to immunometric methods.
• Achieved low intra- and inter-assay variations, ensuring precision and reproducibility.
• Combined cellular assays with physicochemical characterization for enhanced physiological relevance.

Conclusions:

• Cellular bioassays provide a sensitive, reproducible, and pharmacodynamically relevant alternative to traditional in vivo potency determinations.
• These methods offer advantages over immunometry by monitoring downstream signal transduction effects.
• Developed assays are suitable for potency assessment of various bioactive substances and can be adapted for high-throughput screening.